SXTP
60 Degrees Pharmaceuticals, Inc.
Healthcare · Biotechnology · NCM
$1.42
Data: 2026-05-22
✗ ETHICAL FAIL
MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$4M
Total market value of the company
0.00
Rev Growth
-36.8%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About 60 Degrees Pharmaceuticals, Inc.
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
3.8% PASS
Debt must be below 33% of total assets
Cash Ratio
84.2% FAIL
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-85.1%
Historical annualised return based on price data
Days in State
32
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-15 | DOW GEOFFREY S | Chief Executive Officer | 9,670 | $7,759 | |
| 2025-12-11 | DOW GEOFFREY S | Chief Executive Officer | 12,963 | $12,204 | |
| 2025-09-12 | DOW GEOFFREY S | Chief Executive Officer | 7,201 | $9,996 | |
| 2025-06-09 | DOW GEOFFREY S | Chief Executive Officer | 4,376 | $13,065 | |
| 2025-06-03 | XU CHERYL | Director | 5,000 | $14,410 | |
| 2025-01-17 | DOW GEOFFREY S | Chief Executive Officer | 14,394 | — | |
| 2025-01-17 | MILLER TYRONE | Chief Financial Officer | 11,626 | — | |
| 2025-01-17 | LANDON KRISTEN | Chief Operating Officer | 4,540 | — | |
| 2024-12-16 | XU CHERYL | Director | 13,000 | $21,400 | |
| 2024-12-09 | DOW GEOFFREY S | Chief Executive Officer | 73,951 | $89,755 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-22